Literature DB >> 21851940

Cross-cultural adaptation of the Dutch Short Musculoskeletal Function Assessment questionnaire (SMFA-NL): internal consistency, validity, repeatability and responsiveness.

Inge H F Reininga1, Mostafa el Moumni, Sjoerd K Bulstra, Maurits G L Olthof, Klaus W Wendt, Martin Stevens.   

Abstract

The purpose of this study was to translate and culturally adapt the Dutch version of the Short Musculoskeletal Function Assessment questionnaire (SMFA-NL) and to investigate the internal consistency, validity, repeatability and responsiveness of the translated version. The original SMFA was first translated and culturally adapted from English into Dutch according to a standardised procedure and subsequently tested for clinimetric quality. The study population consisted of 162 patients treated for various musculoskeletal injuries or disorders at the departments of Orthopedics and Traumatology. All respondents filled in the SMFA-NL and the SF-36 and a region-specific questionnaire. To determine repeatability, 87 respondents filled in the SMFA-NL for a second time after a time interval of three to four weeks. To determine responsiveness, 29 respondents who were treated for their injury within three months before the first assessment filled in the SMFA-NL for a second time after two to three months. The following analyses were performed to evaluate clinimetric quality of the SMFA-NL: factor analysis and Cronbach's alpha (internal consistency), floor and ceiling effects, Spearman's Rho (construct validity), intraclass correlation coefficients and the Bland & Altman method (repeatability), and standardised response means (SRM) (responsiveness). Factor analysis demonstrated four subscales of the SMFA-NL. Both the newly identified subscales of the SMFA-NL and the conventional subscales of the SMFA showed good internal consistency. No floor and some ceiling effects were found. Construct validity was good, as high correlations were found between the subscales of the SMFA-NL and the respective subscales of the SF-36 and the region-specific questionnaires. Repeatability of the SMFA-NL subscales was high, with no systematic bias between first and second assessment. Responsiveness of the SMFA-NL was moderate, as small to moderate SRMs were found. We successfully translated and culturally adapted a Dutch version of the Short Musculoskeletal Function Assessment questionnaire (SFMA-NL). This study shows that the SMFA-NL is a valid, reliable and moderately responsive method for the assessment of functional status of patients who have a broad range of musculoskeletal disorders. Furthermore, it will allow for comparison between different patient groups as well as for cross-cultural comparisons.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21851940     DOI: 10.1016/j.injury.2011.07.013

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  13 in total

1.  Cross-cultural adaptation and validation of the Danish version of the Short Musculoskeletal Function Assessment questionnaire (SMFA).

Authors:  Marianne Lindahl; Signe Andersen; Annette Joergensen; Christian Frandsen; Liselotte Jensen; Eirikur Benedikz
Journal:  Qual Life Res       Date:  2017-07-04       Impact factor: 4.147

2.  Psychometric properties of the Dutch Short Musculoskeletal Function Assessment (SMFA) questionnaire in patients with a fracture of the upper or lower extremity.

Authors:  M A C Van Son; B L Den Oudsten; J A Roukema; T Gosens; M H J Verhofstad; J De Vries
Journal:  Qual Life Res       Date:  2013-10-20       Impact factor: 4.147

3.  Short Musculoskeletal Function Assessment: normative data of the Dutch population.

Authors:  M W de Graaf; M El Moumni; E Heineman; K W Wendt; I H F Reininga
Journal:  Qual Life Res       Date:  2015-02-13       Impact factor: 4.147

4.  Reliability and validity of the Chinese version of the Short Musculoskeletal Function Assessment questionnaire in patients with skeletal muscle injury of the upper or lower extremities.

Authors:  Ying Wang; Zehui He; Lifang Lei; Dingkun Lin; Yajie Li; Gang Wang; Huimin Zhai; Jingli Xu; Guangqing Zhang; Meizhen Lin
Journal:  BMC Musculoskelet Disord       Date:  2015-07-07       Impact factor: 2.362

5.  Reliability and validity of the Korean version of the Short Musculoskeletal Function Assessment questionnaire for patients with musculoskeletal disorder.

Authors:  Kyoung-Sim Jung; Jin-Hwa Jung; Tae-Sung In; Hwi-Young Cho
Journal:  J Phys Ther Sci       Date:  2016-09-29

6.  American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot Score: a study protocol for the translation and validation of the Dutch language version.

Authors:  Esther M M Van Lieshout; A Siebe De Boer; Duncan E Meuffels; P Ted Den Hoed; Cornelis H Van der Vlies; Wim E Tuinebreijer; Michael H J Verhofstad
Journal:  BMJ Open       Date:  2017-02-27       Impact factor: 2.692

7.  The development and internal validation of a model to predict functional recovery after trauma.

Authors:  Max W de Graaf; Inge H F Reininga; Erik Heineman; Mostafa El Moumni
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

8.  The Short Musculoskeletal Function Assessment: a study of the reliability, construct validity and responsiveness in patients sustaining trauma.

Authors:  Max W de Graaf; Inge Hf Reininga; Klaus W Wendt; Erik Heineman; Mostafa El Moumni
Journal:  Clin Rehabil       Date:  2019-02-06       Impact factor: 3.477

9.  Pelvic ring injury in the elderly: Fragile patients with substantial mortality rates and long-term physical impairment.

Authors:  Hester Banierink; Kaj Ten Duis; Rob de Vries; Klaus Wendt; Erik Heineman; Inge Reininga; Frank IJpma
Journal:  PLoS One       Date:  2019-05-28       Impact factor: 3.240

10.  Cross-Cultural Adaptation and Validation of the Dutch Version of the Hip and Groin Outcome Score (HAGOS-NL).

Authors:  Erwin Brans; Joost S de Graaf; Arvid V E Munzebrock; Bram Bessem; Inge H F Reininga
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.